Alexander Snyder. “For Profit or For Health? It Is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies”. Pittsburgh Journal of Technology Law & Policy 21, no. 2 (August 26, 2021). Accessed October 28, 2021. https://tlp.law.pitt.edu/ojs/tlp/article/view/251.